Latest National Eye Institute Stories
Three young adults who received gene therapy for a blinding eye condition remained healthy and maintained previous visual gains one year later, according to an August online report in Human Gene Therapy.
Omega-3 fatty acids found in fatty fish such as tuna and salmon may protect against progression of age-related macular degeneration (AMD), but the benefits appear to depend on the stage of disease and whether certain supplements are taken, report researchers at the Laboratory for Nutrition and Vision Research (LNVR), Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University.
Researchers are studying the use of a NASA device that can be to test whether a cataract is developing before a patientâ€™s vision begins to cloud over.
U.S. eye doctors collaborated with the National Aeronautics and Space Administration to detect pre-cataract protein changes. Researchers from NASA, the John H.
A compact fiber-optic probe developed for the space program has now proven valuable for patients in the clinic as the first non-invasive early detection device for cataracts, the leading cause of vision loss worldwide.
Researchers said on Tuesday that stem cells from tiny embryos can be used to restore lost hearing and vision in animals, in what they believe is a first step toward helping people.
What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?
Researchers at the National Eye Institute, part of the U.S. National Institutes of Health, reported Monday that 50 percent of Americans have some sort of vision problem, a number that far exceeds previous estimates.
Diabetic retinopathy has been found in nearly 8 percent of pre-diabetic participants in the Diabetes Prevention Program (DPP), according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions. Diabetic retinopathy, which can lead to vision loss, was also seen in 12 percent of participants with type 2 diabetes who developed diabetes during the DPP.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.